Gagnon Securities LLC
- SEC CIK
- 0001125725
- Latest filing
- Aug 4, 2026
ATNM holding history
Actinium Pharmaceuticals, Inc. in every 13F filed by Gagnon Securities LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ATNM overviewAll 13F holders of ATNMFull Q2 2026 holdings
- Shares (Q2 2026)
- 182,142
- Value
- $178.5K
- % of portfolio
- <0.1%
- Quarters held
- 6
- Since Q1 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 182,142 | $178.5K | <0.1% | −19,158−9.5% | Reduced | Holders |
| Q1 2026 | 201,300 | $200.4K | <0.1% | −507−0.3% | Reduced | Holders |
| Q4 2025 | 201,807 | $274.5K | 0.1% | −24,450−10.8% | Reduced | Holders |
| Q3 2025 | 226,257 | $362.0K | 0.1% | −365−0.2% | Reduced | Holders |
| Q2 2025 | 226,622 | $317.3K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 226,622 | $364.9K | 0.1% | +226,622 | New | Holders |